<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31748271</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>49</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>03</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.</ArticleTitle><Pagination><StartPage>24517</StartPage><EndPage>24526</EndPage><MedlinePgn>24517-24526</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1915732116</ELocationID><Abstract><AbstractText>Exonic DNA sequence variants in the <i>Tbk1</i> gene associate with both sporadic and familial amyotrophic lateral sclerosis (ALS). Here, we examine functional defects in 25 missense TBK1 mutations, focusing on kinase activity and protein-protein interactions. We identified kinase domain (KD) mutations that abolish kinase activity or display substrate-specific defects in specific pathways, such as innate immunity and autophagy. By contrast, mutations in the scaffold dimerization domain (SDD) of TBK1 can cause the loss of kinase activity due to structural disruption, despite an intact KD. Familial ALS mutations in ubiquitin-like domain (ULD) or SDD display defects in dimerization; however, a subset retains kinase activity. These observations indicate that TBK1 dimerization is not required for kinase activation. Rather, dimerization seems to increase protein stability and enables efficient kinase-substrate interactions. Our study revealed many aspects of TBK1 activities affected by ALS mutations, highlighting the complexity of disease pathogenicity and providing insights into TBK1 activation mechanism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Junqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Jonah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Special Projects Group, New York Structural Biology Center, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerbino</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahls&#xe9;n</LastName><ForeName>G&#xf6;ran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimanyi</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6782-507X</Identifier><AffiliationInfo><Affiliation>Special Projects Group, New York Structural Biology Center, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsh</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Special Projects Group, New York Structural Biology Center, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maniatis</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032; tm2472@columbia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409460">OPTN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C403191">TBK1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Front Neurosci. 2020 Sep 11;14:551006</RefSource><PMID Version="1">33013311</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055550" MajorTopicYN="N">Protein Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">TBK1</Keyword><Keyword MajorTopicYN="N">dimerization</Keyword><Keyword MajorTopicYN="N">kinase</Keyword><Keyword MajorTopicYN="N">mutations</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31748271</ArticleId><ArticleId IdType="pmc">PMC6900539</ArticleId><ArticleId IdType="doi">10.1073/pnas.1915732116</ArticleId><ArticleId IdType="pii">1915732116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad L., Zhang S. Y., Casanova J. L., Sancho-Shimizu V., Human TBK1: A Gatekeeper of neuroinflammation. Trends Mol. Med. 22, 511&#x2013;527 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgason E., Phung Q. T., Dueber E. C., Recent insights into the complexity of Tank-binding kinase 1 signaling networks: The emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett. 587, 1230&#x2013;1237 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23395801</ArticleId></ArticleIdList></Reference><Reference><Citation>Herhaus L., Dikic I., Expanding the ubiquitin code through post-translational modification. EMBO Rep. 16, 1071&#x2013;1083 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576978</ArticleId><ArticleId IdType="pubmed">26268526</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., et al. , TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174, 1477&#x2013;1491.e19 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnard M., et al. , Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19, 4976&#x2013;4985 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314216</ArticleId><ArticleId IdType="pubmed">10990461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz J. L., Baltimore D., NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18, 6694&#x2013;6704 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K. A., et al. , IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491&#x2013;496 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter S. M., et al. , IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 101, 233&#x2013;238 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314168</ArticleId><ArticleId IdType="pubmed">14679297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., et al. , Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148&#x2013;1151 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12702806</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 124, 783&#x2013;801 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J. X., Chen Z. J., &#x201c;Innate immune sensing and signaling of cytosolic nucleic acids&#x201d; in Annual Review of Immunology, Littman D. R., Yokoyama W. M., Eds. (Annual Reviews, Palo Alto, CA, 2014), vol. 32, pp. 461&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">24655297</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K., Takaoka A., Taniguchi T., Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349&#x2013;360 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16979567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I., &#x201c;Proteasomal and autophagic degradation systems&#x201d; in Annual Review of Biochemistry, Kornberg R. D., Ed. (Annual Reviews, Palo Alto, CA, 2017), vol. 86, pp. 193&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">28460188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Komatsu M., Autophagy: Renovation of cells and tissues. Cell 147, 728&#x2013;741 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B., et al. , Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl. Acad. Sci. U.S.A. 113, 4039&#x2013;4044 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., et al. , Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333, 228&#x2013;233 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman M., et al. , Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209, 1567&#x2013;1582 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428952</ArticleId><ArticleId IdType="pubmed">22851595</ArticleId></ArticleIdList></Reference><Reference><Citation>Awadalla M. S., et al. , Copy number variations of TBK1 in Australian patients with primary open-angle glaucoma. Am. J. Ophthalmol. 159, 124&#x2013;30.e1 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4355400</ArticleId><ArticleId IdType="pubmed">25284765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritch R., et al. , TBK1 gene duplication and normal-tension glaucoma. JAMA Ophthalmol. 132, 544&#x2013;548 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4372533</ArticleId><ArticleId IdType="pubmed">24699864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E. T., et al. ; FALS Sequencing Consortium , Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436&#x2013;1441 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., et al. , Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631&#x2013;636 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A. C., Weishaupt J. H., Andersen P. M.; Association of Mutations in TBK1 With Sporadic and Familial Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol. 74, 110&#x2013;113 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27892983</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J. P., Brown R. H. Jr, Cleveland D. W., Decoding A. L. S., Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J. A., Davies M. C., Collins M. O., TBK1: A new player in ALS linking autophagy and neuroinflammation. Mol. Brain 10, 5 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabi A., et al. , Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 3, 734&#x2013;746 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23453971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu D., et al. , Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3, 747&#x2013;758 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863638</ArticleId><ArticleId IdType="pubmed">23453972</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu C., et al. , Structural insights into the functions of TBK1 in innate antimicrobial immunity. Structure 21, 1137&#x2013;1148 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3702631</ArticleId><ArticleId IdType="pubmed">23746807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., et al. , Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. U.S.A. 109, 9378&#x2013;9383 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386122</ArticleId><ArticleId IdType="pubmed">22619329</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G., et al. , Crystal structure of inhibitor of &#x3ba;B kinase &#x3b2;. Nature 472, 325&#x2013;330 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081413</ArticleId><ArticleId IdType="pubmed">21423167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore N., et al. , IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: Comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 277, 13840&#x2013;13847 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11839743</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K., et al. , Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434, 93&#x2013;104 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21138416</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J.-M., Ordureau A., Paulo J. A., Rinehart J., Harper J. W., The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7&#x2013;20 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Servant M. J., et al. , Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278, 9441&#x2013;9447 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12524442</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanos D., Maniatis T., Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83, 1091&#x2013;1100 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8548797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., et al. , Crystal structure of a human I&#x3ba;B kinase &#x3b2; asymmetric dimer. J. Biol. Chem. 288, 22758&#x2013;22767 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829360</ArticleId><ArticleId IdType="pubmed">23792959</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M., et al. , TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37, 223&#x2013;234 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A., et al. , Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog. Neurobiol. 154, 1&#x2013;20 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., et al. , Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat. Commun. 7, 12708 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027247</ArticleId><ArticleId IdType="pubmed">27620379</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y., Katsuno M., Ikenaka K., Ishigaki S., Sobue G., Amyotrophic lateral sclerosis: An update on recent genetic insights. J. Neurol. 260, 2917&#x2013;2927 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24085347</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G., Wada K., Okuno M., Kurosawa M., Nukina N., Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 44, 279&#x2013;289 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22017874</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G., Shimogori T., Hattori N., Nukina N., TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum. Mol. Genet. 24, 4429&#x2013;4442 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., et al. , Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice. J. Exp. Med. 216, 267&#x2013;278 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363427</ArticleId><ArticleId IdType="pubmed">30635357</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., et al. , Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25636800</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbadia J., Morimoto R. I., The biology of proteostasis in aging and disease. Annu. Rev. Biochem. 84, 435&#x2013;464 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4539002</ArticleId><ArticleId IdType="pubmed">25784053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hipp M. S., Park S. H., Hartl F. U., Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 24, 506&#x2013;514 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24946960</ArticleId></ArticleIdList></Reference><Reference><Citation>Burda J. E., Sofroniew M. V., Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81, 229&#x2013;248 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984950</ArticleId><ArticleId IdType="pubmed">24462092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>